|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein] |
CTD |
PMID:32302048 |
|
NCBI chr14:17,573,412...17,591,476
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression increases activity |
ISO |
citral results in increased expression of AKR1C2 mRNA citral results in increased activity of AKR1C2 promoter |
CTD |
PMID:20491607 PMID:21195160 |
|
NCBI chr17:70,669,684...70,717,935
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
increases oxidation |
EXP |
ALDH1A2 protein results in increased oxidation of citral |
CTD |
PMID:23220587 |
|
NCBI chr 8:71,877,850...71,957,107
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in decreased expression of CAT protein] |
CTD |
PMID:32302048 |
|
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
citral results in increased expression of CD86 protein |
CTD |
PMID:29540657 |
|
NCBI chr11:77,647,565...77,706,178
|
|
G |
Ceacam20 |
CEA cell adhesion molecule 20 |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of CEACAM20 protein] |
CTD |
PMID:32302048 |
|
NCBI chr 1:79,622,077...79,643,782
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
citral results in increased expression of CXCL2 protein |
CTD |
PMID:23178550 |
|
NCBI chr14:17,465,210...17,467,255
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of CYB5A protein] |
CTD |
PMID:32302048 |
|
NCBI chr18:78,213,067...78,245,677
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [CYP1A1 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral |
CTD |
PMID:18824010 |
|
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite |
CTD |
PMID:18824010 |
|
NCBI chr 6:21,093,927...21,103,091
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases activity |
EXP |
citral results in decreased activity of CYP2B1 protein |
CTD |
PMID:9242356 |
|
NCBI chr 1:90,646,098...90,669,762
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [CYP2B6 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; citral inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] |
CTD |
PMID:18611395 PMID:18824010 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite |
CTD |
PMID:18824010 |
|
NCBI chr 1:205,269,967...205,280,365
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
citral inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] |
CTD |
PMID:18385293 |
|
NCBI chr12:14,321,771...14,343,886
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [CYP3A5 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral |
CTD |
PMID:18824010 |
|
NCBI chr12:21,919,955...21,960,160
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
citral results in increased expression of DNAJB4 mRNA |
CTD |
PMID:27965148 |
|
NCBI chr 2:243,790,296...243,819,042
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO |
citral binds to ESR1 protein citral inhibits the reaction [Estradiol binds to ESR1 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding multiple interactions |
ISO |
citral binds to ESR2 protein citral inhibits the reaction [Estradiol binds to ESR2 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
citral results in increased expression of GCLM mRNA |
CTD |
PMID:27965148 |
|
NCBI chr 2:213,032,135...213,052,192
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein] |
CTD |
PMID:32302048 |
|
NCBI chr 7:110,295,599...110,300,134
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in decreased expression of GSR protein] |
CTD |
PMID:32302048 |
|
NCBI chr16:65,185,574...65,228,742
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
citral results in increased expression of HMOX1 mRNA |
CTD |
PMID:20491607 PMID:26244607 |
|
NCBI chr19:13,452,365...13,479,823
|
|
G |
Hoxa1 |
homeobox A1 |
multiple interactions |
ISO |
citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] |
CTD |
PMID:23696197 |
|
NCBI chr 4:81,255,814...81,258,587
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
citral results in increased expression of ICAM1 protein |
CTD |
PMID:29540657 |
|
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[citral co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
citral results in increased expression of IL18 protein |
CTD |
PMID:23063874 |
|
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
citral results in increased expression of IL1A protein |
CTD |
PMID:23178550 |
|
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il2 |
interleukin 2 |
increases secretion multiple interactions |
ISO |
citral results in increased secretion of IL2 protein [citral co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:22245253 PMID:29594315 |
|
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il6 |
interleukin 6 |
increases secretion |
ISO |
citral results in increased secretion of IL6 protein |
CTD |
PMID:22245253 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
citral results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 7:112,792,787...112,804,139
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
EXP |
citral results in increased activity of NQO1 protein |
CTD |
PMID:29389585 |
|
NCBI chr19:52,205,374...52,220,267
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of PCNA protein] |
CTD |
PMID:32302048 |
|
NCBI chr 3:139,951,948...139,955,820
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of POR protein] |
CTD |
PMID:32302048 |
|
NCBI chr12:26,587,674...26,655,612
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
citral results in increased expression of VEGFA protein |
CTD |
PMID:25617811 |
|
NCBI chr 9:22,452,854...22,468,194
|
|
|
G |
Gna15 |
G protein subunit alpha 15 |
increases response to substance multiple interactions |
ISO |
GNA15 protein results in increased susceptibility to citral dimethyl acetal [GNA15 protein results in increased susceptibility to citral dimethyl acetal] which results in increased activity of OR1A1B protein |
CTD |
PMID:15598656 |
|
NCBI chr 7:8,835,396...8,856,269
|
|
G |
Or1a1 |
olfactory receptor family 1 subfamily A member 1 |
multiple interactions |
ISO |
[GNA15 protein results in increased susceptibility to citral dimethyl acetal] which results in increased activity of OR1A1B protein |
CTD |
PMID:15598656 |
|
NCBI chr10:59,058,941...59,059,879
|
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein] |
CTD |
PMID:32302048 |
|
NCBI chr14:17,573,412...17,591,476
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression increases activity |
ISO |
citral results in increased expression of AKR1C2 mRNA citral results in increased activity of AKR1C2 promoter |
CTD |
PMID:20491607 PMID:21195160 |
|
NCBI chr17:70,669,684...70,717,935
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
increases oxidation |
EXP |
ALDH1A2 protein results in increased oxidation of citral |
CTD |
PMID:23220587 |
|
NCBI chr 8:71,877,850...71,957,107
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in decreased expression of CAT protein] |
CTD |
PMID:32302048 |
|
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
citral results in increased expression of CD86 protein |
CTD |
PMID:29540657 |
|
NCBI chr11:77,647,565...77,706,178
|
|
G |
Ceacam20 |
CEA cell adhesion molecule 20 |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of CEACAM20 protein] |
CTD |
PMID:32302048 |
|
NCBI chr 1:79,622,077...79,643,782
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
citral results in increased expression of CXCL2 protein |
CTD |
PMID:23178550 |
|
NCBI chr14:17,465,210...17,467,255
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of CYB5A protein] |
CTD |
PMID:32302048 |
|
NCBI chr18:78,213,067...78,245,677
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [CYP1A1 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral |
CTD |
PMID:18824010 |
|
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite |
CTD |
PMID:18824010 |
|
NCBI chr 6:21,093,927...21,103,091
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases activity |
EXP |
citral results in decreased activity of CYP2B1 protein |
CTD |
PMID:9242356 |
|
NCBI chr 1:90,646,098...90,669,762
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [CYP2B6 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; citral inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] |
CTD |
PMID:18611395 PMID:18824010 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite |
CTD |
PMID:18824010 |
|
NCBI chr 1:205,269,967...205,280,365
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
citral inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] |
CTD |
PMID:18385293 |
|
NCBI chr12:14,321,771...14,343,886
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
[[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral; [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite; [CYP3A5 protein results in increased metabolism of geraniol] which results in increased chemical synthesis of citral |
CTD |
PMID:18824010 |
|
NCBI chr12:21,919,955...21,960,160
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
citral results in increased expression of DNAJB4 mRNA |
CTD |
PMID:27965148 |
|
NCBI chr 2:243,790,296...243,819,042
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO |
citral binds to ESR1 protein citral inhibits the reaction [Estradiol binds to ESR1 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding multiple interactions |
ISO |
citral binds to ESR2 protein citral inhibits the reaction [Estradiol binds to ESR2 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
citral results in increased expression of GCLM mRNA |
CTD |
PMID:27965148 |
|
NCBI chr 2:213,032,135...213,052,192
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein] |
CTD |
PMID:32302048 |
|
NCBI chr 7:110,295,599...110,300,134
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in decreased expression of GSR protein] |
CTD |
PMID:32302048 |
|
NCBI chr16:65,185,574...65,228,742
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
citral results in increased expression of HMOX1 mRNA |
CTD |
PMID:20491607 PMID:26244607 |
|
NCBI chr19:13,452,365...13,479,823
|
|
G |
Hoxa1 |
homeobox A1 |
multiple interactions |
ISO |
citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] |
CTD |
PMID:23696197 |
|
NCBI chr 4:81,255,814...81,258,587
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
citral results in increased expression of ICAM1 protein |
CTD |
PMID:29540657 |
|
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[citral co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
citral results in increased expression of IL18 protein |
CTD |
PMID:23063874 |
|
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
citral results in increased expression of IL1A protein |
CTD |
PMID:23178550 |
|
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il2 |
interleukin 2 |
increases secretion multiple interactions |
ISO |
citral results in increased secretion of IL2 protein [citral co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:22245253 PMID:29594315 |
|
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il6 |
interleukin 6 |
increases secretion |
ISO |
citral results in increased secretion of IL6 protein |
CTD |
PMID:22245253 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
citral results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 7:112,792,787...112,804,139
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
EXP |
citral results in increased activity of NQO1 protein |
CTD |
PMID:29389585 |
|
NCBI chr19:52,205,374...52,220,267
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of PCNA protein] |
CTD |
PMID:32302048 |
|
NCBI chr 3:139,951,948...139,955,820
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
citral inhibits the reaction [Diethylnitrosamine results in increased expression of POR protein] |
CTD |
PMID:32302048 |
|
NCBI chr12:26,587,674...26,655,612
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
citral results in increased expression of VEGFA protein |
CTD |
PMID:25617811 |
|
NCBI chr 9:22,452,854...22,468,194
|
|